Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines
采用合理设计方法在高度侵袭性乳腺癌细胞系中进行新型 Rac1-GEF 信号抑制剂的临床前开发
期刊:Anti-Cancer Agents in Medicinal Chemistry
影响因子:
doi:10.2174/18715206113136660334
Georgina A Cardama, Maria J Comin, Leandro Hornos, Nazareno Gonzalez, Lucas Defelipe, Adrian G Turjanski, Daniel F Alonso, Daniel E Gomez, Pablo Lorenzano Menna
